A new or recurrent diagnosis of uterine cancer often results in fear and confusion for patients and their family members. Understanding treatment options, accessing new and innovative therapies through clinical trials, as well as understanding the role of supportive care and complementary and alternative medicine are essential. Cancer screening, genetic testing and prevention are equally relevant to all individuals, especially those related to someone diagnosed with cancer.
Updates in the Management of Gynecologic Cancers (05/27/2008) A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists
Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (03/31/2008) Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in gynecological cancers difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (03/17/2008) The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.
Risk Factors Identified for Uterine Sarcoma Survival (02/20/2008) Survival for patients diagnosed with uterine leiomyosarcomas may be influenced by several factors. These findings were recently published in the journal Cancer.
Being Overweight Associated with Increased Risk of Several Cancers (02/19/2008) Excess bodyweight increases the risk of developing several types of cancer, according to results recently published in The Lancet.